Контакты | НИАРМЕДИК ПЛЮС

     
 

NEARMEDIC laboratory equipment department

NEARMEDIC responded to the need of the health care system for integrated supplies of modern laboratory instruments and techniques by establishing the department of microbiological laboratory equipment in 1996, which over the last decade has provided services on the complex equipping of laboratories with high-tech tools and devices, as well as their assembly, user-training, launch and follow-up maintenance. A new direction of the NEARMEDIC laboratory equipment department is the provision of automated analyzers, reagents, comprehensive support and services in human genomic identification for forensic medicine. NEARMEDIC extensively cooperates with key international companies - world leaders in laboratory equipment: Abbott Diagnostics (USA), Abbott Molecular (USA), Tecan (Switzerland), Don Whiitley Scientific (Great Britain), Faster (Italy), Europrobe (France), AES Laboratoire (France), Varian (USA), Binder (Germany), Bio Merieux (France), Beckman Coulter (USA), Miele (Germany) and some others – identifying and introducing innovative diagnostic methods, products and modern laboratory technique to the Russian market. A new direction of the NEARMEDIC laboratory equipment department is the provision of automated analyzers, reagents, comprehensive support and services in human genomic identification for forensic medicine. One of the newest projects launched in the collaboration with Abbott Molecular is the registration and introduction into the Russian market of high-throughput unique universal innovative automated PLEX-ID complex (technology, equipment, integrated software and reagents). PLEX-ID is capable of providing fast automated identification (and quantitative assessment) of any infectious agent (viruses, bacteria, fungi, protozoa) and their mixtures presented in a single clinical or non-clinical sample. The technology can simultaneously provide additional data on the detected germs including identity, strain type, taxonomy, virulence, toxicogenicity and existence of genomic mutations leading to drug resistance.